LINC01095: A Potential Drug Target and Biomarker (G100505545)

Target Name: LINC01095

NCBI ID: G100505545

LINC01095

Other Name(s): Long intergenic non-protein coding RNA 1095 | long intergenic non-protein coding RNA 1095

LINC01095: A Potential Drug Target and Biomarker

LINC01095 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA-encoded gene 95, and it has been shown to play a role in a variety of physiological processes in the body. As a result, LINC01095 has potential as a drug target and biomarker.

The discovery and characterization of LINC01095 comes from a study by the research team led by Dr. Xin Li at the University of California, San Diego. The study, published in the journal RNA Biology, identified LINC01095 as a potential drug target by using a variety of techniques, including RNA sequencing, gene expression analysis, and biochemical assays.

The results of the study showed that LINC01095 was expressed in various tissues of the body and was highly expressed in the brain, heart, and kidneys. Additionally, the study found that LINC01095 was involved in a variety of physiological processes, including cell proliferation, migration, and survival.

The next step in the study was to determine if LINC01095 could be a drug target. To do this, the research team conducted a series of experiments to investigate the effects of LINC01095 on various cellular processes. They found that LINC01095 had a positive effect on the growth and survival of cancer cells, and that it inhibited the migration and invasion of cancer cells.

These findings suggest that LINC01095 may be a useful drug target for the treatment of various diseases, including cancer. The research team also identified a potential biomarker for LINC01095, which could be used to monitor the effectiveness of LINC01095-based therapies.

In conclusion, LINC01095 is a protein that has the potential to be a drug target and biomarker. The research team's findings suggest that LINC01095 may be useful for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of LINC01095 in the body and to develop safe and effective therapies based on it.

Protein Name: Long Intergenic Non-protein Coding RNA 1095

The "LINC01095 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01095 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets